Trials / Completed
CompletedNCT01641276
Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hospital Sirio-Libanes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The propose of this study is to identification of a group of specific amplitude-modulated frequencies of low intensity electromagnetic fields that is associated with biofeedback upon exposure to in patients with hepatitis B carries with or without hepatocellular carcinoma.
Detailed description
Patients will be exposed by different specific amplitude-modulated frequencies of low intensity electromagnetic fields for 30 min. During the exposure, autonomic response with be recorded in order to identify biofeedback response. Differences in group of frequencies is expected in patients with hepatitis B carries with or without hepatocellular carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Low intensity amplitude-moduled electromagnetic fields | Patients in each arm will be exposed to 30 min of amplitude-moduled low intensity electromagnetic fields only one time. |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2012-07-16
- Last updated
- 2015-09-14
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01641276. Inclusion in this directory is not an endorsement.